BioMedical Strategy
Management Team

The Team

Orna Oz, Ph.D. - CEO
Dr. Oz is a clinical and regulatory affairs specialist with more than twenty years of experience in the pre-clinical and clinical research fields. Orna is experienced in the management of multidisciplinary research groups. Orna has gained vast experience in project strategic planning, establishment and conducting of animal studies as well as multi-center controlled clinical studies. She graduated with Ph.D. in Medical Physics from the Tel Aviv University where she published pioneering research in the cardiovascular area.


Keren Shtiegman, Ph.D. - Clinical & Regulatory Affairs Consultant
Dr. Shtiegman is a scientific regulatory and clinical affairs consultant with experience in the regulation of medical devices in the U.S and Europe .  Keren has gained experience in preparing and supporting clinical and regulatory strategies, and submissions. Keren has a broad scientific background. She obtained her Ph.D. in Molecular and Cellular Biology from the Weizmann Institute of Science, were she published her scientific work.


From seed to market approval, BioMedical Strategy has the best experts and international alliances to facilitate and optimize the regulatory process.


View Orna Oz & the BioMedical Strategy Group's profile on LinkedIn